Meta-analysis of the impact of alpha-glucosidase inhibitors on incident diabetes and cardiovascular outcomes

BACKGROUND: Alpha-glucosidase inhibitors (AGIs) have been shown to reduce incident type 2 diabetes but their impact on cardiovascular (CV) disease remains controversial. We sought to identify the overall impact of AGIs with respect to incident type 2 diabetes in individuals with impaired glucose tol...

Descripción completa

Detalles Bibliográficos
Autores principales: Coleman, Ruth L., Scott, Charles A. B., Lang, Zhihui, Bethel, M. Angelyn, Tuomilehto, Jaakko, Holman, Rury R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6798440/
https://www.ncbi.nlm.nih.gov/pubmed/31623625
http://dx.doi.org/10.1186/s12933-019-0933-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6798440/
https://www.ncbi.nlm.nih.gov/pubmed/31623625
http://dx.doi.org/10.1186/s12933-019-0933-y

Ejemplares similares